Annual Report

Overview

The report describes FY2018 approvals and registrations for Wafesil and Silcap, continued Phase 2 Wafermine progress, and expansion of Entity nutraceutical sales to 25 Australian pharmacies. It reports consolidated revenue of S$6.53 million and the launch and listing of 15 nutraceutical products. Its Sustainability Statement covers environmental, people, product and governance priorities, while noting that material topics were identified for a planned inaugural Sustainability Report.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2018
Period: Ends 30 June 2018
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services